Skip to content

CBLL

CeriBell, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$24.68
+0.46%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue102.0M89.1M65.4M45.2M25.9M
Cost of Revenue11.3M10.8M8.7M7.1M4.4M
Gross Profit90.6M78.3M56.8M38.2M21.5M
Operating Expenses
R&D Expense23.0M19.1M13.6M9.0M7.2M
SG&A Expense137.7M117.5M82.9M59.2M50.3M
General & Admin Expense53.2M44.5M33.8M20.3M18.5M
Selling & Marketing Expense84.4M73.1M49.1M38.9M31.8M
Other Expenses
Total Operating Expenses160.6M136.7M96.5M68.2M57.5M
Cost and Expenses171.9M147.5M105.2M75.3M61.9M
Operating Income (EBIT)(70.0M)(58.4M)(39.7M)(30.0M)(36.0M)
Non-Operating
Interest Income
Interest Expense1.8M1.9M2.0M2.1M1.6M
Net Interest Income(1.8M)(1.9M)(2.0M)(2.1M)(1.6M)
Other Non-Op Income/Expense4.0M5.0M(746.0K)588.0K(1.1M)
Non-Operating Income (excl Interest)(5.8M)(6.9M)(1.2M)(2.7M)(462.0K)
EBT (Pre-Tax Income)(66.0M)(53.4M)(40.5M)(29.5M)(37.2M)
Income Tax Expense11.0K2.0K
Bottom Line
Net Income(66.0M)(53.4M)(40.5M)(29.5M)(37.2M)
Earnings from Cont. Ops(66.0M)(53.4M)(40.5M)(29.5M)(37.2M)
Earnings from Discont. Ops
Bottom Line Net Income(66.0M)(53.4M)(40.5M)(29.5M)(37.2M)
Per Share
Basic EPS($1.76)($1.46)($1.13)($1.26)($1.59)
Diluted EPS($1.76)($1.46)($1.13)($1.26)($1.59)
Revenue Per Share$2.68$2.44$1.83$1.94$1.11
Shares
Basic Shares Outstanding38.0M36.5M35.9M23.3M23.3M
Diluted Shares Outstanding38.0M36.5M35.9M23.3M23.3M
Profitability Metrics
EBITDA(63.1M)(50.2M)(37.3M)(26.5M)(35.1M)
D&A1.1M1.3M1.1M847.0K497.0K
EBIT(64.2M)(51.5M)(38.5M)(27.4M)(35.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026